Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
East China Normal University currently has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct examiners and a corresponding number of art units. This distribution shows that each pending matter is being handled by a different individual in a different administrative section. Examiner MOAZZAMI, NAGHMEH NINA is identified as the busiest examiner, though they are only responsible for 1 pending office action.
This 1 action is part of the total workload. The variety of 4 distinct art units suggests that the university's filings cover diverse technical sub-sectors within the broader Biotechnology & Pharmaceuticals field. Managing multiple examiners across various units requires a coordination effort to ensure consistency. The university must adapt its prosecution strategy to the specific requirements and examiner tendencies found in each separate environment for its pending matters. Practitioners should monitor the specific habits of MOAZZAMI, NAGHMEH NINA while also tracking the other active files. This decentralized structure means that the outcome of one case may not necessarily predict the results of the others.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOAZZAMI, NAGHMEH NINA | 1 | 71.8% | +49.1% |
| ZAHORIK, AMANDA MARY | 1 | 58.3% | +49.3% |
| CUTLIFF, YATE KAI RENE | 1 | 79.8% | +24.3% |
| BAKSHI, PANCHAM | 1 | 76.7% | +30.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031243 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | BAKSHI, PANCHAM | 14d |
| 18747728 | USE OF SNAT2 COMPETITIVE INHIBITOR OR GENE EXPRESSION INHIBITION IN THE PREPARATION OF DRUGS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION | MOAZZAMI, NAGHMEH NINA | — |
| 18686437 | Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use Thereof | ZAHORIK, AMANDA MARY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18135893 | CONSTRUCTION METHOD AND APPLICATION OF MICROTUBE-BASED IONIC LIQUID COLLOID/WATER INTERFACE | CUTLIFF, YATE KAI RENE | 142d overdue |
| 18031243 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | BAKSHI, PANCHAM | 14d |
| 18747728 | USE OF SNAT2 COMPETITIVE INHIBITOR OR GENE EXPRESSION INHIBITION IN THE PREPARATION OF DRUGS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION | MOAZZAMI, NAGHMEH NINA | — |
| 18686437 | Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use Thereof | ZAHORIK, AMANDA MARY | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1636 | 1 |
| 1692 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18747728 | USE OF SNAT2 COMPETITIVE INHIBITOR OR GENE EXPRESSION INHIBITION IN THE PREPARATION OF DRUGS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION | MOAZZAMI, NAGHMEH NINA | 1652 | §103§112 | Non-Final OA | — | Pending | Jun 19, 2024 |
| 18686437 | Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use Thereof | ZAHORIK, AMANDA MARY | 1636 | §101§102§103§112 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18135893 | CONSTRUCTION METHOD AND APPLICATION OF MICROTUBE-BASED IONIC LIQUID COLLOID/WATER INTERFACE | CUTLIFF, YATE KAI RENE | 1692 | §112 | Non-Final OA | 142d overdue | Pending | Apr 18, 2023 |
| 18031243 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | BAKSHI, PANCHAM | 1623 | §103§112 | Final Rejection | 14d | Pending | Apr 11, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEast China Normal University has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Naghmeh Nina Moazzami has the most, with 1 of East China Normal University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
